SERUM DICKKOPF-1 IS INCREASED AND CORRELATES WITH BONE MINERAL DENSITY IN PATIENTS WITH THALASSEMIA-INDUCED OSTEOPOROSIS. REDUCTION POST ZOLEDRONIC ACID ADMINISTRATION

被引：0
|
作者：
Voskaridou, E. [1 ]
Christoulas, D. [2 ]
Xirakia, C. [1 ]
Varvagiannis, K. [1 ]
Boutsikas, G. [2 ]
Terpos, E. [2 ]
机构：
[1] Laikon Gen Hosp, Thalassemia Ctr, Athens, Greece
[2] Gen AF Hosp, Dept Med Res, Athens, Greece
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0900
引用
收藏
页码：357 / 357
页数：1
相关论文
共 24 条
  • [1] Serum Dickkopf-1 Is Increased and Correlates with Bone Mineral Density in Patients with Thalassemia-induced Osteoporosis. Reduction Post Zoledronic Acid Administration
    Voskaridou, Ersi
    Christoulas, Dimitrios
    Pantelaros, Thodoris
    Varvagiannis, Konstantinos
    Xirakia, Charoula
    Papatheodorou, Athanasios
    Sinopoulou, Kleio
    Mpalasopoulou, Aggeliki
    Bilalis, Antonios
    Terpos, Evangelos
    BLOOD, 2008, 112 (11) : 1325 - 1326
  • [2] Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration
    Voskaridou, Ersi
    Christoulas, Dimitrios
    Xirakia, Charoula
    Varvagiannis, Konstantinos
    Boutsikas, Georgios
    Bilalis, Antonios
    Kastritis, Efstathios
    Papatheodorou, Athanasios
    Terpos, Evangelos
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (05): : 725 - 728
  • [3] Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction postzoledronic acid administration (vol 94, pg 725, 2009)
    Voskaridou, E.
    Christoulas, D.
    Xirakia, C.
    Varvagiannis, K.
    Boutsikas, G.
    Bilalis, A.
    Kastritis, E.
    Papatheodorou, A.
    Terpos, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (08): : 1182 - 1182
  • [4] Effect of zoledronic acid on bone mineral density in thalassemia-induced osteoporosis: Results of a phase II clinical trial.
    Taher, A
    Azar, S
    Shamseddeen, W
    Habr, D
    Inati, A
    Koussa, S
    Mahfouz, R
    Otrock, Z
    BLOOD, 2005, 106 (11) : 36B - 36B
  • [5] Zoledronic acid improves bone mineral density in β-thalassemia patients with osteoporosis: a case control study
    Olgun, Mehtap Evran
    Gurkan, Emel
    Tuli, Abdullah
    CUKUROVA MEDICAL JOURNAL, 2019, 44 (03): : 882 - 890
  • [6] The effect of zoledronic acid on serum Dickkopf-1, osteoprotegerin and rankl in patients with paget's disease of bone
    Polyzos, S. A.
    Anastasilakis, A. D.
    Efstathiadou, Z.
    Kita, M.
    Litsas, I.
    Avramidis, A.
    Arsos, G.
    Moralidis, E.
    Gerou, S.
    Pavlidou, V.
    Papatheodorou, A.
    Terpos, E.
    BONE, 2009, 44 (02) : S289 - S289
  • [7] The Effect of Zoledronic Acid on Serum Dickkopf-1, Osteoprotegerin, and RANKL in Patients with Paget's Disease of Bone
    Polyzos, S. A.
    Anastasilakis, A. D.
    Efstathiadou, Z.
    Kita, M.
    Litsas, I.
    Avramidis, A.
    Arsos, G.
    Moralidis, E.
    Gerou, S.
    Pavlidou, V.
    Papatheodorou, A.
    Terpos, E.
    HORMONE AND METABOLIC RESEARCH, 2009, 41 (11) : 846 - 850
  • [8] Zoledronic acid increases bone mineral density in patients with thalassemia intermedia-induced osteoporosis despite the continuous bone marrow expansion
    Voskaridou, E.
    Christoulas, D.
    Antoniadou, L.
    Tsaftaridis, P.
    Plata, E.
    Terpos, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 342 - 342
  • [9] Zoledronic acid increases bone mineral density in patients with thalassemia intermedia-induced osteoporosis regardless of the incessant bone marrow expansion
    Voskaridou, Ersi
    Christoulas, Dimitrios
    Antoniadou, Lito
    Tsaftaridis, Panagiotis
    Plata, Eleni
    Terpos, Evangelos
    BLOOD, 2007, 110 (11) : 21B - 21B
  • [10] Continuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized, placebo-controlled trial
    Voskaridou, Ersi
    Christoulas, Dimitrios
    Konstantinidou, Marialena
    Tsiftsakis, Evangelos
    Alexakos, Panagiotis
    Terpos, Evangelos
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (10): : 1588 - 1590
123